X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1858) 1858
Book Review (301) 301
Publication (129) 129
Book Chapter (15) 15
Book / eBook (14) 14
Newspaper Article (13) 13
Newsletter (10) 10
Reference (3) 3
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1626) 1626
humans (1617) 1617
female (988) 988
male (931) 931
middle aged (777) 777
cancer (763) 763
oncology (722) 722
gallbladder cancer (702) 702
aged (694) 694
gallbladder (638) 638
gallbladder neoplasms - pathology (609) 609
adult (556) 556
gallbladder neoplasms - genetics (537) 537
carcinoma (386) 386
prognosis (372) 372
tumors (294) 294
immunohistochemistry (287) 287
pathology (283) 283
surgery (283) 283
expression (282) 282
aged, 80 and over (277) 277
cell line, tumor (268) 268
risk factors (268) 268
animals (265) 265
gallbladder neoplasms - metabolism (263) 263
research (247) 247
metastasis (246) 246
gastroenterology & hepatology (243) 243
gallbladder carcinoma (239) 239
genetic aspects (212) 212
analysis (208) 208
health aspects (204) 204
gene expression regulation, neoplastic (196) 196
mice (188) 188
chemotherapy (186) 186
medical prognosis (176) 176
medicine & public health (176) 176
cholangiocarcinoma (173) 173
gene expression (173) 173
proteins (168) 168
neoplasm staging (164) 164
mutation (163) 163
studies (159) 159
diagnosis (156) 156
care and treatment (151) 151
apoptosis (149) 149
gallbladder diseases (149) 149
adenocarcinoma - pathology (145) 145
survival (138) 138
abridged index medicus (136) 136
adenocarcinoma (134) 134
breast-cancer (134) 134
development and progression (134) 134
epidemiology (134) 134
hepatocellular-carcinoma (131) 131
gallstones (130) 130
liver (129) 129
cancer research (127) 127
case-control studies (127) 127
gallbladder neoplasms - mortality (127) 127
polymerase chain reaction (126) 126
bile (125) 125
gallbladder neoplasms - epidemiology (124) 124
cell proliferation (123) 123
medicine (122) 122
research article (121) 121
gallbladder - pathology (115) 115
cholecystectomy (111) 111
patients (111) 111
colorectal-cancer (110) 110
bile duct neoplasms - pathology (109) 109
risk (109) 109
gastroenterology (108) 108
gallbladder neoplasms - drug therapy (107) 107
genetic predisposition to disease (105) 105
cell biology (104) 104
mice, nude (104) 104
retrospective studies (104) 104
gallbladder neoplasms - diagnosis (103) 103
liver cancer (103) 103
gallbladder neoplasms - surgery (102) 102
adenocarcinoma - genetics (99) 99
treatment outcome (98) 98
biliary tract cancer (97) 97
carcinogenesis (97) 97
cancer therapies (96) 96
cells (95) 95
neoplasm invasiveness (95) 95
carcinoma - genetics (94) 94
biomarkers, tumor - genetics (90) 90
genes (89) 89
mortality (89) 89
carcinoma - pathology (88) 88
oncology, experimental (88) 88
signal transduction (88) 88
cell cycle (86) 86
incidence (86) 86
kinases (86) 86
survival analysis (86) 86
k-ras (85) 85
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1854) 1854
Spanish (21) 21
Chinese (18) 18
German (8) 8
Italian (4) 4
Japanese (4) 4
Polish (3) 3
French (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1470 - 1473
Journal Article
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 9, pp. 2839 - 2852
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 819 - 828
Summary Background Gemcitabine plus a platinum-based agent (eg, cisplatin or oxaliplatin) is the standard of care for advanced biliary cancers. We investigated... 
Hematology, Oncology and Palliative Medicine | GROWTH-FACTOR RECEPTOR | MULTICENTER | CISPLATIN | ONCOLOGY | COLORECTAL-CANCER | CLINICAL-TRIALS | GALLBLADDER | COMBINATION | TUMORS | CHEMOTHERAPY | GALL-BLADDER CANCER | ras Proteins - genetics | Peripheral Nervous System Diseases - chemically induced | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Alanine Transaminase - blood | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Oxaliplatin | Common Bile Duct Neoplasms - drug therapy | Adult | Bile Ducts, Intrahepatic | Female | Bile Duct Neoplasms - genetics | Cetuximab | Neutropenia - chemically induced | Common Bile Duct Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Gallbladder Neoplasms - drug therapy | Aspartate Aminotransferases - blood | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Cholangiocarcinoma - genetics | Carcinoma - genetics | Aged | Mutation | Deoxycytidine - analogs & derivatives | Chemotherapy | Product development | Gemcitabine | Comparative analysis | Cancer | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 513, Issue 7516, pp. 110 - 114
Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are among the most common genetic alterations in intrahepatic cholangiocarcinoma (IHCC), a deadly liver... 
PROGENITORS | INTRAHEPATIC CHOLANGIOCARCINOMA | HOMEOSTASIS | LIVER-REGENERATION | MULTIDISCIPLINARY SCIENCES | MUTATION | GROWTH | MICE | PROLIFERATION | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Hepatocyte Nuclear Factor 4 - antagonists & inhibitors | Humans | ras Proteins - metabolism | Hepatocytes - pathology | Male | Hepatocytes - metabolism | Bile Duct Neoplasms - enzymology | Cell Differentiation - genetics | Neoplasm Metastasis | Hepatocyte Nuclear Factor 4 - biosynthesis | Female | Bile Duct Neoplasms - genetics | Cell Lineage - genetics | Cholangiocarcinoma - enzymology | Disease Models, Animal | Cell Division - genetics | Proto-Oncogene Proteins - metabolism | Hepatocyte Nuclear Factor 4 - metabolism | Bile Ducts, Intrahepatic - pathology | Mutant Proteins - genetics | Isocitrate Dehydrogenase - genetics | Mice, Transgenic | Mutant Proteins - metabolism | Proto-Oncogene Proteins - genetics | Hepatocyte Nuclear Factor 4 - genetics | Mutation - genetics | Bile Ducts, Intrahepatic - enzymology | Cholangiocarcinoma - pathology | Animals | Cholangiocarcinoma - genetics | Stem Cells - pathology | Isocitrate Dehydrogenase - metabolism | Glutarates - metabolism | Mice | Bile Duct Neoplasms - pathology | Hepatocytes - enzymology | Index Medicus | Càncer | Diferenciació cel·lular | Gallbladder diseases | Metabolisme | Cell diferentiation | Metabolism | Malalties de la vesícula biliar | Cancer
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 574 - 581
The combination of gemcitabine and oxaliplatin with panitumumab versus gemcitabine and oxaliplatin alone has been evaluated in a phase 2, randomized trial as a... 
KRAS | panitumumab | biliary cancer | chemotherapy | cholangiocarcinoma | gemcitabine and oxaliplatin (GEMOX) | GROWTH-FACTOR-RECEPTOR | GALLBLADDER CANCER | OPEN-LABEL | II TRIAL | CAPECITABINE | ADVANCED CHOLANGIOCARCINOMA | CETUXIMAB | THERAPY | ONCOLOGY | Adenocarcinoma - pathology | Prognosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Adult | Female | Adenocarcinoma - genetics | Bile Duct Neoplasms - genetics | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Bile Ducts, Intrahepatic - pathology | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Treatment Outcome | Adenocarcinoma - drug therapy | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Bile Ducts, Extrahepatic - pathology | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Clinical trials | Usage | Dosage and administration | Gemcitabine | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 518 - 527
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2015, Volume 83, Issue 6, pp. 1228 - 1235
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 135, Issue 4, pp. 1358 - 1368.e4
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 8, pp. 872 - 876
Journal Article
Journal Article